Title:
SUSTAINED ACTION FORMULATION OF CYCLOSPORIN FORM 2
Document Type and Number:
Japanese Patent JP2018048168
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide a formulation for delivering cyclosporin into the conjunctiva for a long duration.SOLUTION: A sustained action formulation comprises cyclosporin A form 2 and a hydrogel selected from hyaluronic acid, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, hydroxyethyl cellulose, polyvinylpyrrolidone, carboxymethyl cellulose, hydroxyethyl cellulose, and polyvinylpyrrolidone.SELECTED DRAWING: None
Inventors:
BLANDA WENDY M
MAYSSA ATTAR
MAYSSA ATTAR
Application Number:
JP2017202536A
Publication Date:
March 29, 2018
Filing Date:
October 19, 2017
Export Citation:
Assignee:
ALLERGAN INC
International Classes:
A61K38/13; A61K9/10; A61K47/32; A61K47/36; A61K47/38; A61P27/02; A61P27/04
Attorney, Agent or Firm:
Shinichiro Tanaka
Disciple Maru Ken
Atsushi Hakoda
Kenji Asai
Kazuo Yamazaki
Satsuki Ichikawa
Hironobu Hattori
Tomoyuki Iwasawa
Disciple Maru Ken
Atsushi Hakoda
Kenji Asai
Kazuo Yamazaki
Satsuki Ichikawa
Hironobu Hattori
Tomoyuki Iwasawa